Investigation of Mechanism Activity of Antitumor and Radiosensitizing Activity of Preparations К-26 and K-26w

A. Ibragimov, Zulfiya Makhmudovna Enikeeva, N. Agzamova, Faizullo Saifyllaevich Salihov, Okiljon Abduhalilovich Rahimov, Mavluda Askarova
{"title":"Investigation of Mechanism Activity of Antitumor and Radiosensitizing Activity of Preparations К-26 and K-26w","authors":"A. Ibragimov, Zulfiya Makhmudovna Enikeeva, N. Agzamova, Faizullo Saifyllaevich Salihov, Okiljon Abduhalilovich Rahimov, Mavluda Askarova","doi":"10.11648/J.AJBLS.20200805.12","DOIUrl":null,"url":null,"abstract":"Introduction. Tropolone alkaloid – colchicine, there is very interesting object for synthesis of its derivatives, with such properties as, alkylation, a low toxicity, high antineoplastic activity and especially overcoming of multidrug resistance (MDR). We had been developed the antineoplastic preparation К-26 derivative of colchicine. К-26 has shown high cytotoxic activity on 60 lines of tumoral cells of the human in vitro, at National Institute of the Cancer of the USA (NCI). Further on the basis of К-26 its water-soluble form named term К-26w has been received. The work purpose. Studying of the mechanism of action of preparations К-26 and К-26w on: alkylating ability, mitotic activity, topoisomerase II, MDR2, р53 and colony-forming cells spleen (CFCs). Materials and methods. All researches have been carrying out by a standard technique. Studying mitotic activity of preparations was carrying out on duodenum and tumor СаРа after preparation influence. On models of a tumor of the Sarcoma 180 action of preparations has been investigated: the alkylating - on synthesis DNA/RNA, nucleosoma DNA degradation, activity topoisomerase II; on an expression MDR2 and р53 genes. Studying CFCs carry out by a standard technique on outbred mice. Results. К-26, К-26w and etoposide inhibited in cells of the Sarcoma 180: synthesis DNA/RNA on 84/65%, 95/85% and 55/35%, accordingly, in relation to the control; activity topoisomerase II on 80%, 90% and 60% accordingly. By method RT-PCR it is shown, К-26, К-26w and etoposide: inhibited an expression of MDR2 gene on 83%, 91% and 62%; increase expression р53 gene to 74%, 88% and 55%, accordingly, under the relation of the control of referential gene GARDH (100%). High ability К-26 and К-26w in an induction apoptosis tumoral cells and CFCs to 12 units is shown. Conclusion. Revealed ability К-26 and К-26w to suppress synthesis DNA/RNA activity topoisomerases, to stimulate р53, and also to suppress an expression of a multidrug resistance MDR2 gene, it explains their high antineoplastic activity which is connected with mitotic activity leading to cell fission synchronization, and radiosensitization activity. Special interest represents found at К-26w and К-26 suppression MDR2 as they are aimed for treatment of such resistant tumor as a kidney cancer. Stimulation CFCs which provides formation of haemopoetic and immune cells can protect an organism from their intensive cytotoxic action.","PeriodicalId":7857,"journal":{"name":"American Journal of Biomedical and Life Sciences","volume":"100 1","pages":"131"},"PeriodicalIF":0.0000,"publicationDate":"2020-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Biomedical and Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11648/J.AJBLS.20200805.12","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Introduction. Tropolone alkaloid – colchicine, there is very interesting object for synthesis of its derivatives, with such properties as, alkylation, a low toxicity, high antineoplastic activity and especially overcoming of multidrug resistance (MDR). We had been developed the antineoplastic preparation К-26 derivative of colchicine. К-26 has shown high cytotoxic activity on 60 lines of tumoral cells of the human in vitro, at National Institute of the Cancer of the USA (NCI). Further on the basis of К-26 its water-soluble form named term К-26w has been received. The work purpose. Studying of the mechanism of action of preparations К-26 and К-26w on: alkylating ability, mitotic activity, topoisomerase II, MDR2, р53 and colony-forming cells spleen (CFCs). Materials and methods. All researches have been carrying out by a standard technique. Studying mitotic activity of preparations was carrying out on duodenum and tumor СаРа after preparation influence. On models of a tumor of the Sarcoma 180 action of preparations has been investigated: the alkylating - on synthesis DNA/RNA, nucleosoma DNA degradation, activity topoisomerase II; on an expression MDR2 and р53 genes. Studying CFCs carry out by a standard technique on outbred mice. Results. К-26, К-26w and etoposide inhibited in cells of the Sarcoma 180: synthesis DNA/RNA on 84/65%, 95/85% and 55/35%, accordingly, in relation to the control; activity topoisomerase II on 80%, 90% and 60% accordingly. By method RT-PCR it is shown, К-26, К-26w and etoposide: inhibited an expression of MDR2 gene on 83%, 91% and 62%; increase expression р53 gene to 74%, 88% and 55%, accordingly, under the relation of the control of referential gene GARDH (100%). High ability К-26 and К-26w in an induction apoptosis tumoral cells and CFCs to 12 units is shown. Conclusion. Revealed ability К-26 and К-26w to suppress synthesis DNA/RNA activity topoisomerases, to stimulate р53, and also to suppress an expression of a multidrug resistance MDR2 gene, it explains their high antineoplastic activity which is connected with mitotic activity leading to cell fission synchronization, and radiosensitization activity. Special interest represents found at К-26w and К-26 suppression MDR2 as they are aimed for treatment of such resistant tumor as a kidney cancer. Stimulation CFCs which provides formation of haemopoetic and immune cells can protect an organism from their intensive cytotoxic action.
К-26和K-26w制剂抗肿瘤活性及放射增敏活性的机制研究
介绍。Tropolone生物碱-秋水仙碱,其衍生物具有烷基化性好、毒性低、抗肿瘤活性高、抗多药耐药能力强等特点,是目前研究的热点。研制了秋水仙碱衍生物К-26抗肿瘤制剂。К-26在美国国家癌症研究所(NCI)对60种体外人类肿瘤细胞显示出高的细胞毒性活性。进一步在К-26的基础上,将其水溶性形式命名为К-26w。工作目的。研究制剂К-26和К-26w对烷基化能力、有丝分裂活性、拓扑异构酶II、MDR2、r53和集落形成细胞脾脏(CFCs)的作用机制。材料和方法。所有的研究都是用标准的技术进行的。研究制剂对十二指肠及肿瘤有丝分裂活性СаРа的影响。对180肉瘤肿瘤模型的作用进行了研究:烷基化-对DNA/RNA的合成,核小体DNA的降解,拓扑异构酶II的活性;表达MDR2和53基因。采用标准方法对异交小鼠进行氟氯化碳的研究。结果。К-26、К-26w和依托泊苷抑制了180肉瘤细胞的DNA/RNA合成,与对照组相比分别为84/65%、95/85%和55/35%;拓扑异构酶II的活性分别为80%、90%和60%。RT-PCR结果表明,К-26、К-26w和依托泊苷对MDR2基因表达的抑制作用分别为83%、91%和62%;在对照参比基因GARDH(100%)的关系下,相应增加了74%、88%和55%的基因表达量。高能力К-26和К-26w诱导凋亡肿瘤细胞和CFCs至12个单位。结论。发现К-26和К-26w能够抑制DNA/RNA活性拓扑异构酶的合成,刺激5353,并抑制多药耐药MDR2基因的表达,这解释了它们的高抗肿瘤活性,这与导致细胞裂变同步的有丝分裂活性和放射致敏活性有关。特别关注的是К-26w和К-26抑制MDR2,因为它们旨在治疗诸如肾癌等耐药肿瘤。刺激氯氟烃提供造血细胞和免疫细胞的形成,可以保护生物体免受其强烈的细胞毒性作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信